Search

everythinglearnresearchcommunity

for

Search:↓

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Hair loss in men and women can cause stress, but new treatments are being developed due to better understanding of its causes.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

More research is needed to find the best long-term treatments for Alopecia Areata.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

New understanding of hair loss could lead to better treatments.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Dermoscopy helps accurately diagnose temporal triangular alopecia, avoiding unnecessary treatments.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Hair loss common in men and women, limited treatments available.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Hair loss in children can be caused by fungal infections, trauma, autoimmune disorders, or stress, and treatments vary depending on the cause.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Alopecia greatly affects Greek women's daily life, relationships, and self-image, with mixed social support and dissatisfaction with treatments.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Minoxidil, finasteride, and PRP are the most effective and accessible treatments for male pattern hair loss.